Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Halozyme Therapeutics ROA 2006-2020 | HALO

Current and historical return on assets (ROA) values for Halozyme Therapeutics (HALO) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
  
Halozyme Therapeutics ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2020-09-30 $0.02B $0.52B 4.17%
2020-06-30 $-0.04B $0.53B -7.98%
2020-03-31 $-0.08B $0.49B -17.33%
2019-12-31 $-0.07B $0.57B -16.15%
2019-09-30 $-0.04B $0.37B -9.66%
2019-06-30 $-0.04B $0.42B -9.93%
2019-03-31 $-0.05B $0.43B -11.40%
2018-12-31 $-0.08B $0.44B -17.25%
2018-09-30 $0.05B $0.45B 9.51%
2018-06-30 $0.08B $0.48B 16.68%
2018-03-31 $0.07B $0.50B 16.07%
2017-12-31 $0.06B $0.52B 17.39%
2017-09-30 $-0.09B $0.36B -29.55%
2017-06-30 $-0.12B $0.35B -43.01%
2017-03-31 $-0.12B $0.23B -43.49%
2016-12-31 $-0.10B $0.26B -35.86%
2016-09-30 $-0.07B $0.28B -26.94%
2016-06-30 $-0.07B $0.30B -28.33%
2016-03-31 $-0.04B $0.31B -17.96%
2015-12-31 $-0.03B $0.18B -18.99%
2015-09-30 $-0.04B $0.16B -24.92%
2015-06-30 $-0.04B $0.17B -22.29%
2015-03-31 $-0.06B $0.16B -33.33%
2014-12-31 $-0.07B $0.17B -38.26%
2014-09-30 $-0.09B $0.17B -52.55%
2014-06-30 $-0.08B $0.18B -56.76%
2014-03-31 $-0.09B $0.20B -70.41%
2013-12-31 $-0.08B $0.10B -76.15%
2013-09-30 $-0.07B $0.11B -55.44%
2013-06-30 $-0.07B $0.11B -56.53%
2013-03-31 $-0.06B $0.12B -47.30%
2012-12-31 $-0.05B $0.14B -42.40%
2012-09-30 $-0.07B $0.11B -62.18%
2012-06-30 $-0.04B $0.12B -41.90%
2012-03-31 $-0.03B $0.14B -27.10%
2011-12-31 $-0.02B $0.07B -25.40%
2011-09-30 $-0.02B $0.08B -22.35%
2011-06-30 $-0.04B $0.09B -39.78%
2011-03-31 $-0.05B $0.08B -63.16%
2010-12-31 $-0.05B $0.09B -69.06%
2010-09-30 $-0.05B $0.10B -66.89%
2010-06-30 $-0.05B $0.05B -73.12%
2010-03-31 $-0.06B $0.07B -69.14%
2009-12-31 $-0.06B $0.08B -71.95%
2009-09-30 $-0.06B $0.09B -76.83%
2009-06-30 $-0.06B $0.10B -74.30%
2009-03-31 $-0.05B $0.07B -68.35%
2008-12-31 $-0.05B $0.08B -56.65%
2008-09-30 $-0.04B $0.08B -44.09%
2008-06-30 $-0.04B $0.09B -36.91%
2008-03-31 $-0.03B $0.10B -29.81%
2007-12-31 $-0.02B $0.10B -24.55%
2007-09-30 $-0.02B $0.11B -22.75%
2007-06-30 $-0.02B $0.10B -26.45%
2007-03-31 $-0.01B $0.07B -36.13%
2006-12-31 $-0.01B $0.05B -56.00%
2006-09-30 $-0.01B $0.02B -74.67%
2006-06-30 $-0.01B $0.02B -87.50%
2006-03-31 $-0.01B $0.02B -96.55%
2005-12-31 $-0.01B $0.02B -105.66%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $5.333B $0.196B
Halozyme Therapeutics, Inc. is a therapeutically driven, development stage biopharmaceutical company dedicated to developing and commercializing recombinant human enzymes for the infertility, ophthalmology, and oncology communities. The company's broad product development portfolio, including expected near- and long-term product offerings, is based on intellectual property covering the family of human enzymes known as hyaluronidases. The company's initial products are being developed to offer safer and purer alternatives toexisting slaughterhouse derived extracts that carry risks of pathogen contamination, immunogenicity, and toxicity. The commercialization of Halozyme's highly versatile enzyme technology within proven markets will enable the company to positively impact the quality of medicine.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $139.404B 9.94
Amgen (AMGN) United States $129.923B 13.58
CSL (CSLLY) Australia $105.271B 0.00
Gilead Sciences (GILD) United States $75.350B 10.02
Vertex Pharmaceuticals (VRTX) United States $55.963B 26.02
Regeneron Pharmaceuticals (REGN) United States $55.353B 19.63
Illumina (ILMN) United States $43.917B 60.40
Moderna (MRNA) United States $38.625B 0.00
Biogen (BIIB) United States $37.570B 6.67
Seagen (SGEN) United States $31.267B 82.58
Alexion Pharmaceuticals (ALXN) United States $26.563B 10.58
BeiGene (BGNE) Cayman Islands $25.802B 0.00
Genmab (GMAB) Denmark $23.927B 28.32
BioNTech SE (BNTX) Germany $23.547B 0.00
Genmab (GNMSF) Denmark $22.674B 5.22
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $18.127B 0.00
Incyte (INCY) United States $17.942B 0.00
Exact Sciences (EXAS) United States $17.333B 0.00
Bio-Rad Laboratories (BIO.B) United States $17.016B 64.52
Horizon Therapeutics Public (HZNP) Ireland $15.483B 22.13
Alnylam Pharmaceuticals (ALNY) United States $14.488B 0.00
BioMarin Pharmaceutical (BMRN) United States $13.787B 91.51
ARGENX SE-ADR (ARGX) Netherlands $12.661B 0.00
Bio-Techne Corp (TECH) United States $11.772B 75.28
Mirati Therapeutics (MRTX) United States $11.408B 0.00
Guardant Health (GH) United States $11.292B 0.00
QIAGEN (QGEN) Netherlands $10.752B 24.21
Sarepta Therapeutics (SRPT) United States $10.352B 0.00
Repligen (RGEN) United States $10.182B 144.41
ACADIA Pharmaceuticals (ACAD) United States $8.516B 0.00
Ascendis Pharma (ASND) Denmark $8.270B 0.00
Galapagos (GLPG) Belgium $8.146B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $7.751B 0.00
Denali Therapeutics (DNLI) United States $7.477B 0.00
Ultragenyx Pharmaceutical (RARE) United States $6.982B 0.00
Acceleron Pharma (XLRN) United States $6.841B 0.00
Adaptive Biotechnologies (ADPT) United States $6.346B 0.00
Exelixis (EXEL) United States $5.867B 39.40
Amicus Therapeutics (FOLD) United States $5.728B 0.00
Reata Pharmaceuticals (RETA) United States $5.514B 0.00
Novavax (NVAX) United States $5.510B 0.00
Blueprint Medicines (BPMC) United States $5.442B 18.02
SWEDISH ORP BIO (BIOVF) Sweden $5.385B 14.71
Twist Bioscience (TWST) United States $5.161B 0.00
NeoGenomics (NEO) United States $4.971B 1492.33
China Biologic Products (CBPO) China $4.674B 27.75
Fate Therapeutics (FATE) United States $4.593B 0.00
Emergent Biosolutions (EBS) United States $4.381B 14.38
Insmed (INSM) United States $3.980B 0.00
Arena Pharmaceuticals (ARNA) United States $3.771B 0.00
Legend Biotech (LEGN) United States $3.735B 0.00
Vir Biotechnology (VIR) United States $3.697B 0.00
Deciphera Pharmaceuticals (DCPH) United States $3.537B 0.00
MorphoSys AG (MOR) Germany $3.510B 127.05
Seres Therapeutics (MCRB) United States $3.147B 0.00
Eidos Therapeutics (EIDX) United States $3.137B 0.00
Alkermes (ALKS) Ireland $2.903B 28.50
Bluebird Bio (BLUE) United States $2.859B 0.00
Global Blood Therapeutics (GBT) United States $2.688B 0.00
Beam Therapeutics (BEAM) United States $2.413B 0.00
I-Mab (IMAB) China $2.331B 0.00
Zymeworks (ZYME) Canada $2.161B 0.00
UniQure (QURE) Netherlands $2.052B 0.00
PHARMA MAR SA (PHMMF) Spain $2.028B 0.00
Intra-Cellular Therapies (ITCI) United States $2.004B 0.00
Sorrento Therapeutics (SRNE) United States $1.988B 0.00
Viela Bio (VIE) United States $1.918B 0.00
Intellia Therapeutics (NTLA) United States $1.911B 0.00
Amarin (AMRN) Ireland $1.807B 0.00
Inovio Pharmaceuticals (INO) United States $1.786B 0.00
Editas Medicine (EDIT) United States $1.772B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.713B 0.00
Mesoblast (MESO) Australia $1.617B 0.00
NGM Biopharmaceuticals (NGM) United States $1.614B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $1.607B 13.30
Mersana Therapeutics (MRSN) United States $1.599B 0.00
Revance Therapeutics (RVNC) United States $1.598B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.586B 0.00
Arcus Biosciences (RCUS) United States $1.583B 0.00
Alcobra (ARCT) United States $1.478B 0.00
Sangamo Therapeutics (SGMO) United States $1.450B 0.00
Zealand Pharma (ZEAL) Denmark $1.430B 0.00
Scholar Rock Holding (SRRK) United States $1.415B 0.00
REGENXBIO (RGNX) United States $1.364B 0.00
Ligand Pharmaceuticals (LGND) United States $1.338B 34.67
Coherus BioSciences (CHRS) United States $1.310B 8.66
Athenex (ATNX) United States $1.308B 0.00
Myriad Genetics (MYGN) United States $1.294B 0.00
Zealand Pharma (ZLDPF) Denmark $1.289B 0.00
Travere Therapeutics (TVTX) United States $1.270B 0.00
Adverum Biotechnologies (ADVM) United States $1.267B 0.00
Heska (HSKA) United States $1.200B 0.00
Intercept Pharmaceuticals (ICPT) United States $1.176B 0.00
Precigen (PGEN) United States $1.170B 0.00
Epizyme (EPZM) United States $1.150B 0.00
Cytokineticsorporated (CYTK) United States $1.132B 0.00
Northwest Biotherapeutics (NWBO) United States $1.095B 0.00
Vericel (VCEL) United States $1.076B 0.00
Codexis (CDXS) United States $1.029B 0.00
Pliant Therapeutics (PLRX) United States $1.015B 0.00
Alector (ALEC) United States $1.001B 0.00
Genetron Holdings (GTH) China $0.997B 0.00
Castle Biosciences (CSTL) United States $0.957B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.941B 0.00
Arvinas (ARVN) United States $0.941B 0.00
Morphic Holding (MORF) United States $0.919B 0.00
Compugen (CGEN) Israel $0.905B 0.00
NantKwest (NK) United States $0.903B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.899B 0.00
Cellectis S.A (CLLS) France $0.899B 0.00
Frequency Therapeutics (FREQ) United States $0.884B 0.00
Protagonist Therapeutics (PTGX) United States $0.831B 0.00
Celldex Therapeutics (CLDX) United States $0.788B 0.00
Cara Therapeutics (CARA) United States $0.764B 0.00
Pharming Group (PHGUF) Netherlands $0.751B 17.14
MiMedx (MDXG) United States $0.734B 0.00
Kadmon Holdings (KDMN) United States $0.731B 0.00
AnaptysBio (ANAB) United States $0.724B 0.00
Agenus (AGEN) United States $0.694B 0.00
Sutro Biopharma (STRO) United States $0.693B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.676B 34.33
Five Prime Therapeutics (FPRX) United States $0.675B 0.00
MannKind (MNKD) United States $0.675B 0.00
Albireo Pharma (ALBO) United States $0.671B 0.00
VBI Vaccines (VBIV) United States $0.666B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.647B 0.00
Cardiff Oncology (CRDF) United States $0.644B 0.00
Sinovac Biotech (SVA) China $0.640B 43.13
Nabriva Therapeutics AG (NBRV) Ireland $0.628B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.606B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.598B 0.00
Geron (GERN) United States $0.584B 0.00
Precision BioSciences (DTIL) United States $0.563B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.525B 0.00
IVERIC Bio (ISEE) United States $0.519B 0.00
Forte Biosciences (FBRX) United States $0.517B 0.00
Anika Therapeutics (ANIK) United States $0.515B 69.62
Avid Bioservices (CDMO) United States $0.509B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.490B 0.00
MeiraGTx Holdings (MGTX) United States $0.488B 0.00
Dynavax Technologies (DVAX) United States $0.487B 0.00
Merus (MRUS) Netherlands $0.473B 0.00
Prothena (PRTA) Ireland $0.468B 0.00
Amryt Pharma (AMYT) United Kingdom $0.446B 0.00
Puma Biotechnology (PBYI) United States $0.444B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.439B 0.00
UROGEN PHARMA (URGN) United States $0.430B 0.00
WAVE Life Sciences (WVE) Singapore $0.421B 0.00
Kala Pharmaceuticals (KALA) United States $0.421B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.414B 0.00
Spero Therapeutics (SPRO) United States $0.413B 0.00
Starpharma Holdings (SPHRY) Australia $0.404B 0.00
BioDelivery Sciences (BDSI) United States $0.403B 19.00
Trevena (TRVN) United States $0.391B 0.00
AC Immune SA (ACIU) Switzerland $0.390B 0.00
Innate Pharma S.A (IPHA) France $0.387B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.386B 0.00
Affimed (AFMD) Germany $0.377B 0.00
Clovis Oncology (CLVS) United States $0.374B 0.00
Cue Biopharma (CUE) United States $0.370B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.365B 0.00
XOMA (XOMA) United States $0.360B 0.00
Syros Pharmaceuticals (SYRS) United States $0.358B 0.00
Cellular Biomedicine (CBMG) United States $0.356B 0.00
Selecta Biosciences (SELB) United States $0.348B 0.00
ANI Pharmaceuticals (ANIP) United States $0.346B 8.81
CytomX Therapeutics (CTMX) United States $0.338B 0.00
Athersys (ATHX) United States $0.324B 0.00
Kamada (KMDA) Israel $0.302B 14.13
ChromaDex (CDXC) United States $0.301B 0.00
Arbutus Biopharma (ABUS) United States $0.285B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.282B 0.00
NextCure (NXTC) United States $0.281B 0.00
PDL BioPharma (PDLI) United States $0.280B 0.00
Fortress Biotech (FBIO) United States $0.265B 0.00
DBV Technologies S.A (DBVT) France $0.260B 0.00
Verastem (VSTM) United States $0.251B 0.00
TELA Bio (TELA) United States $0.250B 0.00
HOOKIPA Pharma (HOOK) United States $0.246B 0.00
Pluristem Therapeutics (PSTI) Israel $0.236B 0.00
Aptinyx (APTX) United States $0.207B 0.00
Bellus Health (BLU) Canada $0.194B 0.00
Aptevo Therapeutics (APVO) United States $0.189B 0.00
POXEL SA FRANCE (PXXLF) France $0.185B 0.00
Strongbridge Biopharma (SBBP) United States $0.181B 0.00
Eton Pharmaceuticals (ETON) United States $0.178B 0.00
Theratechnologies (THTX) Canada $0.178B 0.00
Dyadic (DYAI) United States $0.178B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.177B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.176B 0.00
GENFIT S.A (GNFT) France $0.176B 0.00
ADMA Biologics Inc (ADMA) United States $0.175B 0.00
Cerecor (CERC) United States $0.174B 0.00
AquaBounty Technologies (AQB) United States $0.174B 0.00
Nicox SA (NICXF) France $0.170B 0.00
Checkpoint Therapeutics (CKPT) United States $0.164B 0.00
Biofrontera AG (BFRA) Germany $0.163B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.156B 0.00
Oncobiologics (OTLK) United States $0.153B 0.00
SESEN BIO, INC (SESN) United States $0.153B 0.00
Kindred Biosciences (KIN) United States $0.152B 0.00
Idera Pharmaceuticals (IDRA) United States $0.150B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.148B 0.00
VTv Therapeutics (VTVT) United States $0.143B 0.00
Abeona Therapeutics (ABEO) United States $0.135B 0.00
Lumos Pharma (LUMO) United States $0.134B 0.00
Catalyst Biosciences (CBIO) United States $0.128B 0.00
Celyad SA (CYAD) Belgium $0.127B 0.00
Exicure (XCUR) United States $0.126B 0.00
Aytu Bioscience (AYTU) United States $0.122B 0.00
Antibe Therapeutics (ATBPF) Canada $0.120B 0.00
Liquidia Technologies (LQDA) United States $0.119B 0.00
Cogent Biosciences (COGT) United States $0.116B 0.00
TRACON Pharmaceuticals (TCON) United States $0.115B 0.00
Prometic Life Sciences (LMNL) Canada $0.115B 0.00
Orgenesis (ORGS) United States $0.114B 236.50
Windtree Therapeutics (WINT) United States $0.111B 0.00
Cidara Therapeutics (CDTX) United States $0.106B 0.00
Gritstone Oncology (GRTS) United States $0.106B 0.00
PhaseBio Pharaceuticals (PHAS) United States $0.104B 0.00
Applied Genetic Technologies (AGTC) United States $0.103B 0.00
Cyclerion Therapeutics (CYCN) United States $0.102B 0.00
Novogen (KZIA) Australia $0.098B 0.00
AIT Therapeutics (XAIR) United States $0.093B 0.00
Enzo Biochem (ENZ) United States $0.093B 0.00
ARAVIVE, INC (ARAV) United States $0.088B 0.00
Clearside Biomedical (CLSD) United States $0.086B 0.00
Ecology Coatings (ABVC) United States $0.083B 0.00
Bionano Genomics (BNGO) United States $0.080B 0.00
DiaMedica Therapeutics (DMAC) United States $0.080B 0.00
Curis (CRIS) United States $0.076B 0.00
Prima BioMed (IMMP) Australia $0.074B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.074B 0.00
Evogene (EVGN) Israel $0.073B 0.00
Synlogic (SYBX) United States $0.072B 0.00
Stealth BioTherapeutics (MITO) United States $0.068B 32.50
MiRagen Therapeutics (MGEN) United States $0.067B 0.00
Adocia (ADOCY) France $0.067B 0.00
Soligenix (SNGX) United States $0.066B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.064B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.062B 0.00
Cocrystal Pharma (COCP) United States $0.061B 0.00
Organovo Holdings (ONVO) United States $0.060B 0.00
Emmaus Life Sciences (EMMA) United States $0.056B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.056B 0.00
Proteostasis Therapeutics (PTI) United States $0.054B 0.00
Appili Therapeutics (APLIF) Canada $0.053B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.053B 0.00
Vascular Biogenics (VBLT) Israel $0.050B 0.00
Happiness Biotech Group (HAPP) China $0.049B 0.00
Edesa Biotech (EDSA) Canada $0.049B 0.00
Vaccinex (VCNX) United States $0.044B 0.00
CollPlant Holdings (CLGN) Israel $0.043B 0.00
Seelos Therapeutics (SEEL) United States $0.042B 0.00
Genetic Technologies (GENE) Australia $0.042B 0.00
IMMURON (IMRN) Australia $0.042B 0.00
Cleveland BioLabs (CBLI) United States $0.041B 0.00
Titan Pharmaceuticals (TTNP) United States $0.040B 0.00
AnPac Bio-Medical Science (ANPC) China $0.038B 0.00
Pulmatrix (PULM) United States $0.038B 0.00
ATyr Pharma (LIFE) United States $0.034B 0.00
Acorda Therapeutics (ACOR) United States $0.034B 0.00
Chanticleer Holdings (SONN) United States $0.033B 0.00
OvaScience (MLND) United States $0.032B 0.00
BioCardia (BCDA) United States $0.030B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.027B 0.00
AEterna Zentaris (AEZS) United States $0.026B 0.00
Advaxis (ADXS) United States $0.025B 0.00
Alimera Sciences (ALIM) United States $0.024B 0.00
Prana Biotechnology (ATHE) Australia $0.023B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.023B 0.00
Cesca Therapeutics (THMO) United States $0.021B 0.00
Celsion (CLSN) United States $0.020B 0.00
Spherix (AIKI) United States $0.018B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.017B 0.00
Invo BioScience (INVO) United States $0.016B 0.00
MedAvail Holdings (MDVL) United States $0.012B 0.00
Neuralstem (SNCA) United States $0.011B 0.00
GeoVax Labs (GOVX) United States $0.010B 0.00
Benitec Biopharma (BNTC) Australia $0.003B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00
Osmotica Pharmaceuticals (OSMT) United States $0.000B 0.00
Zai Lab (ZLAB) China $0.000B 0.00